- Home
- FAMI vs TOVX Comparison
FAMI vs TOVX Comparison
Compare FAMI & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FAMI | TOVX |
|---|---|---|
| Founded | 2015 | 2001 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7M | 7.3M |
| IPO Year | 2018 | 2006 |
Fundamental Metrics
Financial Performance| Metric | FAMI | TOVX |
|---|---|---|
| Price | $1.48 | $0.22 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.8K | ★ 2.6M |
| Earning Date | 01-26-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,831,754.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.26 | $0.20 |
| 52 Week High | $7.07 | $2.08 |
Technical Indicators
Market Signals| Indicator | FAMI | TOVX |
|---|---|---|
| Relative Strength Index (RSI) | 44.81 | 42.46 |
| Support Level | $1.45 | $0.21 |
| Resistance Level | $1.54 | $0.25 |
| Average True Range (ATR) | 0.10 | 0.03 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 65.09 | 33.02 |
Price Performance
Historical ComparisonAbout FAMI Farmmi Inc.
Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.